Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A small human study on chronic pain patients showed significant reductions in pain levels for 6 out of 7 subjects after DSIP treatment
Key supporting research from 2024-2025 includes a July 2024 paper in Inflammopharmacology (PMID: 38980576) linking BPC-157 to stress response mechanisms, a January 2025 HSS Journal systematic review on neuromuscular applications (PMID: 40756949), and a 2025 Journal of Neuropsychiatry and Clinical Neurosciences perspectives paper positioning BPC-157 as an emerging therapeutic for CNS disorders
In addition, butyrate treatment attenuated CIA onset (Fig
Advanced injectable protocol Goal: Maximum efficacy, willing to inject, committed to comprehensive protocol
.jpg)
US$ 29.95
US$ 29.08
US$ 26.99
US$ 22.17
US$ 24.43
